By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Interleukin Genetics announced after the close of the market Thursday that revenues for the third quarter rose 41 percent year over year.

Total revenues increased to $765,416 for the three months ended Sept. 30, from $544,744 a year ago, as genetic testing service revenue rose 38 percent to $731,194 from $531,151. Other revenues came in at $34,222, up 152 percent from $13,593 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.

The American Society of Human Genetics has issued a position statement on genetic testing of children.

The White House seeks to update how biotechnology products are regulated.

Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.